- Last edited on February 5, 2024
Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Last revision Both sides next revision | ||
geri:dementia:lewy-body [on February 5, 2024] psychdb [Neuroimaging] |
geri:dementia:lewy-body [on February 5, 2024] psychdb [Neuroimaging] |
||
---|---|---|---|
Line 134: | Line 134: | ||
* **<sup>123</sup>Iodine-metaiodobenzylguanidine myocardial scintigraphy (MIBG)** may show low striatal dopamine transporter uptake | * **<sup>123</sup>Iodine-metaiodobenzylguanidine myocardial scintigraphy (MIBG)** may show low striatal dopamine transporter uptake | ||
* **<sup>123</sup>I-ioflupane single-photon emission computed tomography (SPECT)** or dopamine transporter (DAT) scans | * **<sup>123</sup>I-ioflupane single-photon emission computed tomography (SPECT)** or dopamine transporter (DAT) scans | ||
- | * <sup>123</sup>I-ioflupane single-photon emission computed tomography (SPECT) assesses DAT uptake in the basal ganglia in vivo, and has been shown to be more specific than clinical diagnostic criteria for DLB. | + | * This assesses DAT uptake in the basal ganglia in vivo, and has been shown to be more specific than clinical diagnostic criteria for DLB. |
* It maybe the most reliable imaging modality of choice in differentiating DLB from pure AD. | * It maybe the most reliable imaging modality of choice in differentiating DLB from pure AD. | ||
* **Fluorodeoxyglucose PET (FDG PET)** may show occipital hypometabolism | * **Fluorodeoxyglucose PET (FDG PET)** may show occipital hypometabolism |